Infectious Diseases in Critical Care Medicine

(ff) #1

  1. Rubin RH, Marty FM. Principles of antimicrobial therapy in the transplant patient. Transpl Infect Dis
    2004; 6(3):97–100.

  2. Martinelli L, Rinaldi M, Pederzolli C, et al. Different results of cardiac transplantation in patients
    with ischemic and dilated cardiomyopathy. Eur J Cardiothorac Surg 1995; 9(11):644–650.

  3. Mun ̃oz P, Mun ̃oz RM, Palomo J, et al.Pneumocystis cariniiinfections in heart transplant patients.
    Twice a week prophylaxis. Medicine (Baltimore) 1997; 76:415–422.

  4. Edwards LB, Keck BM. Thoracic organ transplantation in the US. Clin Transpl 2002:29–40.

  5. Detre KM, Belle SH, Carr MA, et al. A report from the NIDDK Liver Transplantation Database. Clin
    Transpl 1989:129–141.

  6. Ben Hamida C, Lauzet JY, Rezaiguia-Delclaux S, et al. Effect of severe thrombocytopenia on patient
    outcome after liver transplantation. Intensive Care Med 2003; 29(5):756–762.

  7. Aggarwal A, Ong JP, Goormastic M, et al. Survival and resource utilization in liver transplant
    recipients: the impact of admission to the intensive care unit. Transplant Proc 2003; 35(8):2998–3002.

  8. Wiebe K, Wahlers T, Harringer W, et al. Lung transplantation for cystic fibrosis—a single center
    experience over 8 years. Eur J Cardiothorac Surg 1998; 14(2):191–196.

  9. Madden BP, Kamalvand K, Chan CM, et al. The medical management of patients with cystic fibrosis
    following heart-lung transplantation. Eur Respir J 1993; 6(7):965–970.

  10. Nath DS, Kandaswamy R, Gruessner R, et al. Fungal infections in transplant recipients receiving
    alemtuzumab. Transplant Proc 2005; 37(2):934–936.

  11. Peleg AY, Husain S, Kwak EJ, et al. Opportunistic infections in 547 organ transplant recipients
    receiving alemtuzumab, a humanized monoclonal CD-52 antibody. Clin Infect Dis 2007;
    44(2):204–212.

  12. Hunt SA, Frazier OH. Mechanical circulatory support and cardiac transplantation. Circulation 1998;
    97(20):2079–2090.

  13. Argenziano M, Catanese KA, Moazami N, et al. The influence of infection on survival and successful
    transplantation in patients with left ventricular assist devices. J Heart Lung Transplant 1997;
    16(8):822–831.

  14. Fischer SA, Trenholme GM, Costanzo MR, et al. Infectious complications in left ventricular assist
    device recipients. Clin Infect Dis 1997; 24(1):18–23.

  15. Masters RC, Hendry PJ, Davies RA, et al. Cardiac transplantation after mechanical circulatory
    support: a canadian perspective. Ann Thorac Surg 1996; 61:1734–1739.

  16. Bouza E, Mun ̃oz P, Rodriguez C, et al. Endotipsitis: an emerging prosthetic-related infection in
    patients with portal hypertension. Diagn Microbiol Infect Dis 2004; 49(2):77–82.

  17. Pietrantoni C, Minai OA, Yu NC, et al. Respiratory failure and sepsis are the major causes of ICU
    admissions and mortality in survivors of lung transplants. Chest 2003; 123(2):504–509.

  18. Lardinois D, Banysch M, Korom S, et al. Extended donor lungs: eleven years experience in a
    consecutive series. Eur J Cardiothorac Surg 2005; 27(5):762–767.

  19. Cuende N, Miranda B, Canon JF, et al. Donor characteristics associated with liver graft survival.
    Transplantation 2005; 79(10):1445–1452.

  20. Moreno A, Cervera C, Gavalda J, et al. Bloodstream infections among transplant recipients: results of
    a nationwide surveillance in Spain. Am J Transplant 2007; 7(11):2579–2586.

  21. Rodriguez C, Mun ̃oz P, Rodriguez-Creixems M, et al. Bloodstream infections among heart
    transplant recipients. Transplantation 2006; 81(3):384–391.

  22. Ostrowsky BE, Venkataraman L, D’Agata EM, et al. Vancomycin-resistant enterococci in intensive
    care units: high frequency of stool carriage during a non-outbreak period. Arch Intern Med 1999;
    159(13):1467–1472.

  23. Park YS, Seo JB, Lee YK, et al. Radiological and clinical findings of pulmonary aspergillosis
    following solid organ transplant. Clin Radiol 2008; 63(6):673–680.

  24. Mort TC, Yeston NS. The relationship of pre mortem diagnoses and post mortem findings in a
    surgical intensive care unit [see comments]. Crit Care Med 1999; 27(2):299–303.

  25. Singh N, Paterson DL.Mycobacterium tuberculosisinfection in solid-organ transplant recipients:
    impact and implications for management. Clin Infect Dis 1998; 27(5):1266–1277.

  26. Mun ̃oz P, Guinea J, Pelaez T, et al. Nosocomial invasive aspergillosis in a heart transplant patient
    acquired during a break in the HEPA air filtration system. Transpl Infect Dis 2004; 6(1):50–54.

  27. Mun ̃oz P, Arencibia J, Rodriguez C, et al. Trimethoprim-sulfamethoxazole as toxoplasmosis
    prophylaxis for heart transplant recipients. Clin Infect Dis 2003; 36(7):932–933; author reply 933.

  28. Singh N, Gayowski T, Wagener MM, et al. Pulmonary infiltrates in liver transplant recipients in the
    intensive care unit. Transplantation 1999; 67(8):1138–1144.

  29. Papanicolaou GA, Meyers BR, Meyers J, et al. Nosocomial infections with vancomycin-resistant
    Enterococcus faeciumin liver transplant recipients: risk factors for acquisition and mortality. Clin
    Infect Dis 1996; 23(4):760–766.


Infections in Organ Transplants in Critical Care 409

Free download pdf